Mast cells: Multifaceted immune cells with diverse roles in health and disease

Annals of the New York Academy of Sciences

Volumn 1143, Issue , 2008, Pages 83-104

  Rao, Kavitha N ^a   Brown, Melissa A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Allergy; Autoimmune disease; Cancer; Cardiovascular disease; Degranulation; Homeostasis; Mast cells; Multiple sclerosis; Rheumatoid arthritis; Tissue remodeling

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; COMPLEMENT RECEPTOR; FC RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; TOLL LIKE RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ADAPTIVE IMMUNITY; ALLERGY; ANTIBODY AFFINITY; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BASOPHIL; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CELL FUNCTION; CELL HOMING; CELL INTERACTION; CELL MATURATION; CELL POPULATION; CHRONIC INFLAMMATION; CYTOLOGY; HEART DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HOST RESISTANCE; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INNATE IMMUNITY; MAST CELL; MOLECULAR DYNAMICS; MULTIPLE SCLEROSIS; NEOPLASM; NERVOUS SYSTEM; NONHUMAN; PARASITOSIS; PATHOGENESIS; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; TISSUE ENGINEERING; VIRUS INFECTION; WOUND HEALING;

MUS;

EID: 56549122816     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1443.023     Document Type: Review

References (189)

1. Ehrlich, P. 1878. Beitrage zur Theorie und Praxis der Histologischen Farbung. Leipzig University, Germany.
2. Crivellato, E. et al. 2003. Paul Ehrlich's doctoral thesis: a milestone in the study of mast cells. Br. J. Haematol. 123 : 19 21.
3. Kitamura, Y., S. Go & K. Hatanaka. 1978. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52 : 447 452.
4. Galli, S.J. & M. Tsai. 2008. Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J. Dermatol. Sci. 49 : 7 19.
5. Grimbaldeston, M.A. et al. 2005. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167 : 835 848.
6. Kitamura, Y. et al. 1993. Development of mast cells and basophils: processes and regulation mechanisms. Am. J. Med. Sci. 306 : 185 191.
7. Kitamura, Y. et al. 1977. Development of mast cells from grafted bone marrow cells in irradiated mice. Nature 268 : 442 443.
8. Fodinger, M. et al. 1994. Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood 84 : 2954 2959.
9. Crapper, R.M. & J.W. Schrader. 1983. Frequency of mast cell precursors in normal tissues determined by an in vitro assay: antigen induces parallel increases in the frequency of P cell precursors and mast cells. J. Immunol. 131 : 923 928.
10. Guy-Grand, D. et al. 1984. Gut mucosal mast cells. Origin, traffic, and differentiation. J. Exp. Med. 160 : 12 28.
11. Kitamura, Y. & J. Fujita. 1989. Regulation of mast cell differentiation. Bioessays 10 : 193 196.
12. Rodewald, H.R. et al. 1996. Identification of a committed precursor for the mast cell lineage. Science 271 : 818 822.
13. Jamur, M.C. et al. 2005. Identification and characterization of undifferentiated mast cells in mouse bone marrow. Blood 105 : 4282 4289.
14. Chen, C.C. et al. 2005. Identification of mast cell progenitors in adult mice. Proc. Natl. Acad. Sci. USA 102 : 11408 11413.
15. Arinobu, Y. et al. 2005. Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc. Natl. Acad. Sci. USA 102 : 18105 18110.
16. Gurish, M.F. & J.A. Boyce. 2006. Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell. J. Allergy Clin. Immunol. 117 : 1285 1291.
17. Abonia, J.P. et al. 2005. Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood 105 : 4308 4313.
18. Pennock, J.L. & R.K. Grencis. 2004. In vivo exit of c-kit+/CD49 d(hi)/beta7 +mucosal mast cell precursors from the bone marrow following infection with the intestinal nematode Trichinella spiralis. Blood 103 : 2655 2660.
19. Maximow, A. 1906. Uber die zellformen des lockeren bindesgewebes. Arch. Mikrosk. Anat. 67 : 680 757.
20. Enerback, L. 1966. Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties. Acta. Pathol. Microbiol. Scand. 66 : 303 312.
21. Enerback, L. 1966. Mast cells in rat gastrointestinal mucosa. I. Effects of fixation. Acta. Pathol. Microbiol. Scand. 66 : 289 302.
22. Hallgren, J. & M.F. Gurish. 2007. Pathways of murine mast cell development and trafficking: tracking the roots and routes of the mast cell. Immunol. Rev. 217 : 8 18.
23. Kitamura, Y. 1989. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol. 7 : 59 76.
24. Welle, M. 1997. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J. Leukoc. Biol. 61 : 233 245.
25. Ruitenberg, E.J. & A. Elgersma. 1976. Absence of intestinal mast cell response in congenitally athymic mice during Trichinella spiralis infection. Nature 264 : 258 260.
26. Irani, A.A. et al. 1986. Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. USA 83 : 4464 4468.
27. Irani, A.M. et al. 1987. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J. Immunol. 138 : 4381 4386.
28. Bradding, P. et al. 1995. Heterogeneity of human mast cells based on cytokine content. J. Immunol. 155 : 297 307.
29. McNeil, H.P. & I. Gotis-Graham. 2000. Human mast cell subsets-distinct functions in inflammation? Inflamm. Res. 49 : 3 7.
30. Marshall, J.S. 2004. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4 : 787 799.
31. Supajatura, V. et al. 2002. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109 : 1351 1359.
32. Stelekati, E., Z. Orinska & S. Bulfone-Paus. 2007. Mast cells in allergy: innate instructors of adaptive responses. Immunobiology 212 : 505 519.
33. Supajatura, V. et al. 2001. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J. Immunol. 167 : 2250 2256.
34. Orinska, Z. et al. 2005. TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood 106 : 978 987.
35. Nigo, Y.I. et al. 2006. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proc. Natl. Acad. Sci. USA 103 : 2286 2291.
36. Matsushima, H. et al. 2004. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J. Immunol. 173 : 531 541.
37. Varadaradjalou, S. et al. 2003. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 33 : 899 906.
38. Zhu, F.G. & J.S. Marshall. 2001. CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells. J. Leukoc. Biol. 69 : 253 262.
39. Malaviya, R. et al. 1999. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc. Natl. Acad. Sci. USA 96 : 8110 8115.
40. Daeron, M., A. Prouvost-Danon & G.A. Voisin. 1980. Mast cell membrane antigens and Fc receptors in anaphylaxis. II. Functionally distinct receptors for IgG and for IgE on mouse mast cells. Cell Immunol. 49 : 178 189.
41. Tkaczyk, C. et al. 2004. Fcgamma receptors on mast cells: activatory and inhibitory regulation of mediator release. Int. Arch. Allergy Immunol. 133 : 305 315.
42. Bischoff, S.C. 2007. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat. Rev. Immunol. 7 : 93 104.
43. Woolhiser, M.R. et al. 2001. IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma. Eur. J. Immunol. 31 : 3298 3307.
44. Galli, S.J. et al. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23 : 749 786.
45. Gilfillan, A.M. & C. Tkaczyk. 2006. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6 : 218 230.
46. Kinet, J.P. 1999. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu. Rev. Immunol. 17 : 931 972.
47. Rivera, J. & A.M. Gilfillan. 2006. Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 117 : 1214 1225 quiz, 1226.
48. Abramson, J. & I. Pecht. 2007. Regulation of the mast cell response to the type 1 Fc epsilon receptor. Immunol. Rev. 217 : 231 254.
49. Kawakami, T. & S.J. Galli. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2 : 773 786.
50. Kawakami, T. & J. Kitaura. 2005. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J. Immunol. 175 : 4167 4173.
51. Anthony, R.M. et al. 2007. Protective immune mechanisms in helminth infection. Nat. Rev. Immunol. 7 : 975 987.
52. Gurish, M.F. et al. 2004. IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis. J. Immunol. 172 : 1139 1145.
53. Pennock, J.L. & R.K. Grencis. 2006. The mast cell and gut nematodes: damage and defence. Chem. Immunol. Allergy 90 : 128 140.
54. Melendez, A.J. et al. 2007. Inhibition of Fc epsilon RI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes. Nat. Med. 13 : 1375 1381.
55. Malbec, O. & M. Daeron. 2007. The mast cell IgG receptors and their roles in tissue inflammation. Immunol. Rev. 217 : 206 221.
56. Genovese, A. et al. 2000. Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. Infect. Immun. 68 : 5517 5524.
57. Patella, V. et al. 2000. HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI +cells through interaction with the VH3 region of IgE. J. Immunol. 164 : 589 595.
58. Muller-Eberhard, H.J. 1988. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57 : 321 347.
59. Dawicki, W. & J.S. Marshall. 2007. New and emerging roles for mast cells in host defence. Curr. Opin. Immunol. 19 : 31 38.
60. Fureder, W. et al. 1995. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J. Immunol. 155 : 3152 3160.
61. Nilsson, G. et al. 1996. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J. Immunol. 157 : 1693 1698.
62. Prodeus, A.P. et al. 1997. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390 : 172 175.
63. Edelson, B.T. et al. 2006. Novel collectin/C1q receptor mediates mast cell activation and innate immunity. Blood 107 : 143 150.
64. Crivellato, E. et al. 2003. Piecemeal degranulation as a general secretory mechanism? Anat. Rec. A Discov. Mol. Cell Evol Biol. 274 : 778 784.
65. Xiang, Z. et al. 2001. IgE-mediated mast cell degranulation and recovery monitored by time-lapse photography. J. Allergy Clin. Immunol. 108 : 116 121.
66. Pejler, G. et al. 2007. Mast cell proteases. Adv. Immunol. 95 : 167 255.
67. Kolset, S.O. & L. Zernichow. 2008. Serglycin and secretion in human monocytes. Glycoconj J. 25 : 305 311.
68. Matsumoto, R. et al. 1995. Packaging of proteases and proteoglycans in the granules of mast cells and other hematopoietic cells. A cluster of histidines on mouse mast cell protease 7 regulates its binding to heparin serglycin proteoglycans. J. Biol. Chem. 270 : 19524 19531.
69. Ringvall, M. et al. 2008. Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan. J. Allergy Clin. Immunol. 121 : 1020 1026.
70. Sandig, H., J.E. Pease & I. Sabroe. 2007. Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function. J. Leukoc. Biol. 81 : 372 382.
71. Di Nardo, A., A. Vitiello & R.L. Gallo. 2003. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170 : 2274 2278.
72. Maurer, M. et al. 2003. What is the physiological function of mast cells? Exp. Dermatol. 12 : 886 910.
73. Abe, M. et al. 2000. Effect of mast cell-derived mediators and mast cell-related neutral proteases on human dermal fibroblast proliferation and type I collagen production. J. Allergy Clin. Immunol. 106 : S78 S84.
74. Artuc, M., U.M. Steckelings & B.M. Henz. 2002. Mast cell-fibroblast interactions: human mast cells as source and inducers of fibroblast and epithelial growth factors. J. Invest. Dermatol. 118 : 391 395.
75. Garbuzenko, E. et al. 2002. Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin. Exp. Allergy 32 : 237 246.
76. Noli, C. & A. Miolo. 2001. The mast cell in wound healing. Vet. Dermatol. 12 : 303 313.
77. Metcalfe, D.D., D. Baram & Y.A. Mekori. 1997. Mast cells. Physiol. Rev. 77 : 1033 1079.
78. Weller, K. et al. 2006. Mast cells are required for normal healing of skin wounds in mice. Faseb J. 20 : 2366 2368.
79. Maurer, M. et al. 1997. Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab. Invest. 77 : 319 332.
80. Maurer, M., R. Paus & B.M. Czarnetzki. 1995. Mast cells as modulators of hair follicle cycling. Exp. Dermatol. 4 : 266 271.
81. Paus, R., T. Christoph & S. Muller-Rover. 1999. Immunology of the hair follicle: a short journey into terra incognita. J. Investig. Dermatol. Symp. Proc. 4 : 226 234.
82. Cindik, E.D. et al. 2000. Phenotypical characterization of c-kit receptor deficient mouse femora using non-destructive high-resolution imaging techniques and biomechanical testing. Technol. Health Care 8 : 267 275.
83. Silberstein, R. et al. 1991. Bone remodeling in W/Wv mast cell deficient mice. Bone 12 : 227 236.
84. Chiappetta, N. & B. Gruber. 2006. The role of mast cells in osteoporosis. Semin Arthritis Rheum 36 : 32 36.
85. Bulfone-Paus, S. & R. Paus. 2008. Osteopontin as a new player in mast cell biology. Eur. J. Immunol. 38 : 338 341.
86. Nagasaka, A. et al. 2008. Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur. J. Immunol. 38 : 489 499.
87. Hultner, L. & H. Ehrenreich. 2005. Mast cells and endothelin-1: a life-saving biological liaison? Trends Immunol. 26 : 235 238.
88. Maurer, M. et al. 2004. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432 : 512 516.
89. Metz, M. et al. 2006. Mast cells can enhance resistance to snake and honeybee venoms. Science 313 : 526 530.
90. Furuno, T. et al. 2005. The spermatogenic Ig superfamily/synaptic cell adhesion molecule mast-cell adhesion molecule promotes interaction with nerves. J. Immunol. 174 : 6934 6942.
91. Suzuki, A. et al. 2004. N-cadherin plays a role in the synapse-like structures between mast cells and neurites. Biol. Pharm. Bull. 27 : 1891 1894.
92. Van Nassauw, L., D. Adriaensen & J.P. Timmermans. 2007. The bidirectional communication between neurons and mast cells within the gastrointestinal tract. Auton Neurosci. 133 : 91 103.
93. Chrousos, G.P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332 : 1351 1362.
94. Theoharides, T.C. & D.E. Cochrane. 2004. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 146 : 1 12.
95. Paus, R., T.C. Theoharides & P.C. Arck. 2006. Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol. 27 : 32 39.
96. Cao, J. et al. 2005. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J. Immunol. 174 : 7665 7675.
97. Theoharides, T.C. et al. 1998. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139 : 403 413.
98. Alard, P. et al. 1999. Local ultraviolet B irradiation impairs contact hypersensitivity induction by triggering release of tumor necrosis factor-alpha from mast cells. Involvement of mast cells and Langerhans cells in susceptibility to ultraviolet B. J. Invest. Dermatol. 113 : 983 990.
99. Hart, P.H. et al. 1998. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J. Exp. Med. 187 : 2045 2053.
100. Ullrich, S.E., D.X. Nghiem & P. Khaskina. 2007. Suppression of an established immune response by UVA-a critical role for mast cells. Photochem. Photobiol. 83 : 1095 1100.
101. Byrne, S.N., A.Y. Limon-Flores & S.E. Ullrich. 2008. Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression. J. Immunol. 180 : 4648 4655.
102. Seiffert, K. & R.D. Granstein. 2002. Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. Methods 28 : 97 103.
103. Hart, P.H., M.A. Grimbaldeston & J.J. Finlay-Jones. 2000. Mast cells in UV-B-induced immunosuppression. J. Photochem. Photobiol. B. 55 : 81 87.
104. Hart, P.H. et al. 2002. Mast cells, neuropeptides, histamine, and prostaglandins in UV-induced systemic immunosuppression. Methods 28 : 79 89.
105. Ullrich, S.E. 2005. Mechanisms underlying UV-induced immune suppression. Mutat. Res. 571 : 185 205.
106. Townley, S.L. et al. 2002. Nerve growth factor, neuropeptides, and mast cells in ultraviolet-B-induced systemic suppression of contact hypersensitivity responses in mice. J. Invest. Dermatol. 118 : 396 401.
107. Maurer, M. & M. Metz. 2005. The status quo and quo vadis of mast cells. Exp. Dermatol. 14 : 923 929.
108. Echtenacher, B., D.N. Mannel & L. Hultner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381 : 75 77.
109. Malaviya, R. et al. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381 : 77 80.
110. Malaviya, R. & S.N. Abraham. 2001. Mast cell modulation of immune responses to bacteria. Immunol. Rev. 179 : 16 24.
111. Malaviya, R. & S.N. Abraham. 2000. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J. Leukoc. Biol. 67 : 841 846.
112. Piliponsky, A.M. et al. 2008. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat. Med. 14 : 392 398.
113. Orinska, Z. et al. 2007. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat. Med. 13 : 927 934.
114. Stover, C.M. et al. 2008. Properdin plays a protective role in polymicrobial septic peritonitis. J. Immunol. 180 : 3313 3318.
115. Gommerman, J.L. et al. 2000. A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. J. Immunol. 165 : 6915 6921.
116. Maurer, M. et al. 1998. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med. 188 : 2343 2348.
117. Malaviya, R. et al. 1994. Mast cell phagocytosis of FimH-expressing enterobacteria. J. Immunol. 152 : 1907 1914.
118. Grencis, R.K. 1997. Th2-mediated host protective immunity to intestinal nematode infections. Philos Trans. R. Soc. Lond. B. Biol. Sci. 352 : 1377 1384.
119. Knight, P.A. et al. 2000. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. J. Exp. Med. 192 : 1849 1856.
120. Woodbury, R.G. et al. 1984. Mucosal mast cells are functionally active during spontaneous expulsion of intestinal nematode infections in rat. Nature 312 : 450 452.
121. Lantz, C.S. et al. 1998. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392 : 90 93.
122. Crowle, P.K. & N.D. Reed. 1981. Rejection of the intestinal parasite Nippostrongylus brasiliensis by mast cell-deficient W/Wv anemic mice. Infect. Immun. 33 : 54 58.
123. Faulkner, H. et al. 1998. Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris. Infect. Immun. 66 : 3832 3840.
124. Newlands, G.F. et al. 1995. Stem cell factor contributes to intestinal mucosal mast cell hyperplasia in rats infected with Nippostrongylus brasiliensis or Trichinella spiralis, but anti-stem cell factor treatment decreases parasite egg production during N brasiliensis infection. Blood 86 : 1968 1976.
125. McDermott, J.R. et al. 2003. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc. Natl. Acad. Sci. USA 100 : 7761 7766.
126. Shin, K. et al. 2008. Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection. J. Immunol. 180 : 4885 4891.
127. Furuta, T. et al. 2006. Protective roles of mast cells and mast cell-derived TNF in murine malaria. J. Immunol. 177 : 3294 3302.
128. Henderson, W.R. Jr. & E.Y. Chi. 1998. The importance of leukotrienes in mast cell-mediated Toxoplasma gondii cytotoxicity. J. Infect. Dis. 177 : 1437 1443.
129. Li, E. et al. 2007. Mast cell-mediated changes in smooth muscle contractility during mouse giardiasis. Infect. Immun. 75 : 4514 4518.
130. Li, E. et al. 2004. Mast cell-dependent control of Giardia lamblia infections in mice. Infect. Immun. 72 : 6642 6649.
131. Marshall, J.S., C.A. King & J.D. McCurdy. 2003. Mast cell cytokine and chemokine responses to bacterial and viral infection. Curr. Pharm. Des. 9 : 11 24.
132. Patella, V. et al. 1998. Endogenous superallergen protein Fv induces IL-4 secretion from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. J. Immunol. 161 : 5647 5655.
133. Burke, S.M. et al. 2008. Human mast cell activation with virus associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8 dependent mechanism. Blood 111 : 5467 4576.
134. Marone, G. et al. 2001. Are mast cells MASTers in HIV-1 infection? Int. Arch. Allergy Immunol. 125 : 89 95.
135. Sundstrom, J.B. et al. 2004. Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. J. Immunol. 172 : 4391 4401.
136. Fox, C.C., S.D. Jewell & C.C. Whitacre. 1994. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell Immunol. 158 : 253 264.
137. Frandji, P. et al. 1993. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151 : 6318 6328.
138. Frandji, P. et al. 1996. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur. J. Immunol. 26 : 2517 2528.
139. Henz, B.M. et al. 2001. Mast cells as initiators of immunity and host defense. Exp. Dermatol. 10 : 1 10.
140. Malaviya, R. et al. 1996. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J. Immunol. 156 : 1490 1496.
141. Kambayashi, T. et al. 2008. Indirect involvement of allergen-captured mast cells in antigen presentation. Blood 111 : 1489 1496.
142. Sayed, B.A. & M.A. Brown. 2007. Mast cells as modulators of T-cell responses. Immunol. Rev. 217 : 53 64.
143. Galli, S.J., S. Nakae & M. Tsai. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6 : 135 142.
144. Nakae, S. et al. 2006. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J. Immunol. 176 : 2238 2248.
145. Christy, A.L. & M.A. Brown. 2007. The multitasking mast cell: positive and negative roles in the progression of autoimmunity. J. Immunol. 179 : 2673 2679.
146. Jawdat, D.M., G. Rowden & J.S. Marshall. 2006. Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J. Immunol. 177 : 1755 1762.
147. Bryce, P.J. et al. 2004. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 20 : 381 392.
148. Tanzola, M.B. et al. 2003. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171 : 4385 4391.
149. Sayed, B.A. et al. 2008. The master switch: the role of mast cells in autoimmunity and tolerance. Annu. Rev. Immunol. 26 : 705 739.
150. Gregory, G.D. et al. 2006. Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. J. Clin. Invest. 116 : 1327 1336.
151. Gregory, G.D. et al. 2005. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur. J. Immunol. 35 : 3478 3486.
152. Lu, L.F. et al. 2006. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442 : 997 1002.
153. Grimbaldeston, M.A. et al. 2007. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat. Immunol. 8 : 1095 1104.
154. Depinay, N. et al. 2006. Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites. J. Immunol. 176 : 4141 4146.
155. Brown, J.M., T.M. Wilson & D.D. Metcalfe. 2008. The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin. Exp. Allergy 38 : 4 18.
156. Grimbaldeston, M.A. et al. 2006. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr. Opin. Immunol. 18 : 751 760.
157. Williams, C.M. & S.J. Galli. 2000. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J. Allergy Clin. Immunol. 105 : 847 859.
158. Obata, K. et al. 2007. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood 110 : 913 920.
159. Bachelet, I., F. Levi-Schaffer & Y.A. Mekori. 2006. Mast cells: not only in allergy. Immunol. Allergy Clin. North Am. 26 : 407 425.
160. Benoist, C. & D. Mathis. 2002. Mast cells in autoimmune disease. Nature 420 : 875 878.
161. Rottem, M. & Y.A. Mekori. 2005. Mast cells and autoimmunity. Autoimmun. Rev. 4 : 21 27.
162. Leighty, L. et al. 2007. Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid. Arch. Dermatol. Res. 299 : 417 422.
163. Chen, R. et al. 2001. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J. Clin. Invest. 108 : 1151 1158.
164. Nelson, K.C. et al. 2006. Role of different pathways of the complement cascade in experimental bullous pemphigoid. J. Clin. Invest. 116 : 2892 2900.
165. Kobayashi, Y. & H. Okunishi. 2002. Mast cells as a target of rheumatoid arthritis treatment. Jpn. J. Pharmacol. 90 : 7 11.
166. Lee, D.M. et al. 2002. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297 : 1689 1692.
167. Nigrovic, P.A. et al. 2007. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc. Natl. Acad. Sci. USA 104 : 2325 2330.
168. Blank, U. et al. 2007. Mast cells and inflammatory kidney disease. Immunol. Rev. 217 : 79 95.
169. Sospedra, M. & R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23 : 683 747.
170. Steinman, L. & S.S. Zamvil. 2005. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 26 : 565 571.
171. Langrish, C.L. et al. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201 : 233 240.
172. Secor, V.H. et al. 2000. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191 : 813 822.
173. Robbie-Ryan, M. et al. 2003. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J. Immunol. 170 : 1630 1634.
174. Kovanen, P.T. 2007. Mast cells: multipotent local effector cells in atherothrombosis. Immunol. Rev. 217 : 105 122.
175. Reid, A.C., R.B. Silver & R. Levi. 2007. Renin: at the heart of the mast cell. Immunol. Rev. 217 : 123 140.
176. Chester, A.H. 2002. Mast cells feel the strain. Cardiovasc. Res. 55 : 13 15.
177. Jeziorska, M., C. McCollum & D.E. Woolley. 1997. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. J. Pathol. 182 : 115 122.
178. Patella, V. et al. 1998. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 97 : 971 978.
179. Hara, M. et al. 2002. Evidence for a role of mast cells in the evolution to congestive heart failure. J. Exp. Med. 195 : 375 381.
180. Sun, J. et al. 2007. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat. Med. 13 : 719 724.
181. Sun, J. et al. 2007. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J. Clin. Invest. 117 : 3359 3368.
182. Conti, P. et al. 2007. Role of mast cells in tumor growth. Ann. Clin. Lab. Sci. 37 : 315 322.
183. Ribatti, D. et al. 2001. The role of mast cells in tumour angiogenesis. Br. J. Haematol. 115 : 514 521.
184. Soucek, L. et al. 2007. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat. Med. 13 : 1211 1218.
185. Huang, B. et al. 2008. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 112 : 1269 1279.
186. Hedstrom, G. et al. 2007. Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma. Br. J. Haematol. 138 : 68 71.
187. Rajput, A.B. et al. 2008. Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases. Breast Cancer Res. Treat 107 : 249 257.
188. Sinnamon, M.J. et al. 2008. A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis 29 : 880 886.
189. Leslie, M. 2007. Mast cells show their might. Science 317 : 614 616.